Ready to buy? Check current prices on Amazon and compare deals before you decide.
Navigating the mood shifts that can accompany perimenopause is a common experience for many women. Changes in hormone levels can influence emotional well-being, leading some to explore natural health approaches.
Among the many botanicals discussed for mood support, Ashwagandha and St. John’s Wort often come up. This article will carefully examine the current evidence surrounding ashwagandha vs st johns wort, focusing on their potential roles in supporting mood during perimenopause, and highlight important considerations for their use.
Understanding Ashwagandha for Mood Support
Ashwagandha (Withania somnifera) is an adaptogenic herb traditionally used in Ayurvedic medicine. Adaptogens are substances believed to help the body adapt to various stressors. Research suggests Ashwagandha may influence pathways related to stress and mood [1].
While specific research on Ashwagandha’s effects during perimenopause is still developing, general studies on its impact on mood and stress are available. Some reviews indicate Ashwagandha’s potential for anxiolytic (anxiety-reducing) and antidepressant actions [2][1]. It is thought to interact with various neurochemical systems in the brain that are involved in mood regulation [1].
It’s important to note that while promising, many studies are foundational or conducted on general populations, and more targeted research on women experiencing perimenopausal mood changes would be beneficial. The evidence strength for its role in mood support is considered moderate.
Understanding St. John’s Wort for Mood Support
St. John’s Wort (Hypericum perforatum) is another well-known herb often discussed for its potential to support mood. Its use for emotional well-being has a long history, particularly in European traditional practices. Active compounds like hypericin and hyperforin are believed to contribute to its effects [3].
Clinical data suggests St. John’s Wort may have antidepressant effects [2][3]. It is thought to influence neurotransmitter levels in the brain, similar to some conventional mood-supporting approaches [3].
Similar to Ashwagandha, while general evidence supports its use for mood, specific, large-scale studies focusing on St. John’s Wort’s efficacy during perimenopause are less abundant. The evidence strength for its role in mood support is also considered moderate.
Ashwagandha vs. St. John’s Wort: Key Differences and Considerations
When comparing ashwagandha vs st johns wort, their primary mechanisms of action are generally viewed as distinct. Ashwagandha is considered an adaptogen, helping the body manage stress responses, which can indirectly influence mood. St. John’s Wort, on the other hand, is more directly associated with modulating neurotransmitter levels in the brain to support mood [2][1].
One of the most critical differences lies in their potential for interactions. St. John’s Wort is well-known for its significant interactions with a wide range of medications, including oral contraceptives, antidepressants, blood thinners, and many others [2]. These interactions can diminish the effectiveness of medications or increase their side effects, making careful consideration and professional guidance essential.
Ashwagandha generally has fewer documented medication interactions compared to St. John’s Wort, though it’s always prudent to discuss any supplement use with a healthcare provider, especially if taking other medications. Both herbs have been reviewed for their safety and potential toxicological risks, with St. John’s Wort having more notable interaction warnings [2].
Safety and Side Effects
Both Ashwagandha and St. John’s Wort are generally considered safe for most people when used appropriately, but they are not without potential side effects or contraindications. Ashwagandha is typically well-tolerated, with mild side effects such as digestive upset reported in some individuals. Individuals with autoimmune conditions should use Ashwagandha with caution, as it may stimulate the immune system [4].
St. John’s Wort can cause side effects such as sensitivity to sunlight, dizziness, dry mouth, and gastrointestinal issues [2]. Its extensive drug interaction profile is a major safety concern that cannot be overstated. It is crucial to inform your healthcare provider about all supplements you are taking, especially if considering St. John’s Wort, due to the risk of serious interactions with prescription medications [2].
For women in perimenopause, it is particularly important to consider how these herbs might interact with any hormone therapy or other medications being used to manage menopausal symptoms or pre-existing conditions.
Making an Informed Choice
Given the nuances of perimenopause and the distinct profiles of Ashwagandha and St. John’s Wort, choosing between them for mood support requires careful thought and professional input. There isn’t a definitive ‘better’ option, as individual responses and circumstances vary greatly.
If medication interactions are a significant concern, Ashwagandha might be considered a potentially lower-risk option in that regard, though consultation is still vital. If exploring St. John’s Wort, a thorough review of all current medications with a healthcare provider is absolutely essential to avoid adverse interactions [2].
Ultimately, the decision should be made in consultation with a healthcare professional who can assess your overall health, current medications, and specific perimenopausal symptoms to help determine the most appropriate and safest approach for your mood support.
References
- Rhodiola rosea, Ginkgo biloba, and Ashwagandha as novel antidepressant supplements: converging monoaminergic, neurotrophic, anti-inflammatory, and brain health pathways in depressive disorders. Frontiers in nutrition, 2026
- Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks. Pharmaceuticals (Basel, Switzerland), 2026
- Herbal medicines in the treatment of psychiatric disorders: 10-year updated review. Phytotherapy research : PTR, 2018
- Dose-dependent in vivo effect of Rhodiola and Echinacea on the mitogen-induced lymphocyte proliferation in mice. Polish journal of veterinary sciences, 2011
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
